Skip to main content

Table.1 Univariate logistic regression analyses of factors associated with the use of complementary therapies among patients with systemic lupus erythematosus

From: Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study

Variable

n (%)

Odds ratio (95% CI)

P

Total

Regular use of complementary therapies

  

351 (100)

Use

300 (85.5)

Non-use

51 (14.5)

  

Sex

 Male

34 (9.7)

28 (82.4)

6 (17.6)

1

 

 Female

317 (90.3)

272 (85.8)

45 (14.2)

1.30 (0.51–3.30)

0.588

Age interval (years)

 20–39

140 (39.9)

110 (78.6)

30 (21.4)

1

 

  ≥ 40

211 (60.1)

190 (90.0)

21 (10.0)

2.47 (1.35–4.52)

0.003

Body mass index

 Normal weight

184 (52.4)

165 (89.7)

19 (10.3)

1

 

 Underweight

48 (13.7)

41 (85.4)

7 (14.6)

0.67 (0.27–1.71)

0.407

 Overweight or obesity

119 (33.9)

94 (79.0)

25 (21.0)

0.43 (0.23–0.83)

0.011

Educational level

 High school or below

177 (50.4)

150 (84.7)

27 (15.3)

1

 

 College or above

174 (49.6)

150 (86.2)

24 (13.8)

1.12 (0.62–2.04)

0.698

Marital status

 Single

118 (33.6)

98 (83.1)

20 (16.9)

1

 

 Married, widowed, or divorced

233 (66.4)

202 (86.7)

31 (13.3)

1.33 (0.72–2.45)

0.361

Job change related to SLE

 No

248 (70.7)

213 (85.9)

35 (14.1)

1

 

 Yes

103 (29.3)

87 (84.5)

16 (15.5)

0.89 (0.47–1.70)

0.731

Employment status

 Employed

222 (63.2)

186 (83.8)

36 (16.2)

1

 

 Unemployed

129 (36.8)

114 (88.4)

15 (11.6)

1.47 (0.77–2.81)

0.242

Self-report health status

 Healthy

92 (26.2)

78 (84.8)

14 (15.2)

1

 

 Not healthy or average

259 (73.8)

222 (85.7)

37 (14.3)

1.08 (0.55–2.10)

0.828

Disease duration, years

  < 10

126 (35.9)

104 (82.5)

22 (17.5)

1

 

  ≥ 10

225 (64.1)

196 (87.1)

29 (12.9)

1.43 (0.78–2.61)

0.245

Age at diagnosis, years

 0–29

186 (53.0)

153 (82.3)

33 (17.7)

1

 

  ≥ 30

165 (47.0)

147 (89.1)

18 (10.9)

1.76 (0.95–3.27)

0.072

Alcohol use in the past year

 Yes

81 (23.1)

61 (75.3)

20 (24.7)

1

 

 No

270 (76.9)

239 (88.5)

31 (11.5)

2.53 (1.35–4.74)

0.004

Smoking in the past year

 Yes

34 (9.7)

25 (73.5)

9 (26.5)

1

 

 No

317 (90.3)

275 (86.8)

42 (13.2)

2.36 (1.03–5.40)

0.042

Vigorous exercise in the past year

 Never

60 (17.1)

43 (71.7)

17 (28.3)

1

 

 Yes

291 (82.9)

257 (88.3)

34 (11.7)

2.99 (1.54–5.82)

0.001

Sleep duration/day, hours

  ≥ 8

69 (19.7)

43 (71.7)

17 (28.3)

1

 

  ≤ 7

282 (80.3)

257 (88.3)

34 (11.7)

2.99 (1.54–5.82)

0.001

Sleeping medication use

 No

253 (72.1)

210 (83.0)

43 (17.0)

1

 

 Yes

98 (27.9)

90 (91.8)

8 (8.2)

2.30 (1.04–5.10)

0.039

SLEDAI-2 K, mean (SD) (n = 333)

4.9 (4.4)

4.7 (4.1)

6.2 (5.9)

0.94 (0.88–1.00)

0.035

Domain of LupusQoL, mean (SD)

 Physical health

81.3 (19.9)

80.1 (20.0)

88.4 (17.6)

0.74 (0.59–0.92)

0.008

 Emotional health

83.2 (19.8)

82.8 (19.9)

85.5 (18.8)

0.92 (0.78–1.09)

0.362

 Body image (n = 340)

82.9 (23.0)

83.0 (22.8)

82.5 (24.8)

1.01 (0.89–1.15)

0.904

 Pain

80.2 (26.5)

79.7 (26.9)

83.5 (23.6)

0.94 (0.83–1.07)

0.344

 Planning

81.2 (26.2)

80.7 (26.7)

84.6 (23.0)

0.94 (0.83–1.06)

0.319

 Fatigue

72.0 (23.5)

71.4 (23.7)

75.5 (21.9)

0.92 (0.81–1.06)

0.253

 Intimate relationships (n = 271)

74.3 (33.2)

72.9 (34.6)

81.4 (23.7)

0.92 (0.82–1.03)

0.129

 Burden to others

72.0 (29.9)

71.4 (30.3)

79.1 (27.4)

0.91 (0.81–1.02)

0.094

  1. CI confidence interval, SD standard deviation, SLE systemic lupus erythematosus, SLEDAI-2 K Systemic Lupus Erythematosus Disease Activity Index 2000
  2. The score of LupusQoL was multiplied by 10 in the regression analysis, and therefore, the odds ratio was per 10-point change in LupusQoL